Skip to main content
. 2015 Apr 28;70(1):119–124. doi: 10.1007/s12070-015-0845-4

Table 1.

Demographic data of patients having normal and abnormal IMT

IMT p
<1 mm (n:162) mean ± SD ≥1 mm (n:53) mean ± SD
Gender
 Male 54 (33.3 %) 30 (56.6 %) 0.003*
 Female 108 (66.7 %) 23 (43.4 %)
Age (years) 49.04 ± 13.67 59.40 ± 7.79 0.001*
Duration of Tinnitus (month) 42.29 ± 45.56 48.16 ± 47.57 0.421
Hearing loss
 Present 111 (68.5 %) 47 (88.7 %) 0.004*
 Non-present 51 (31.5 %) 6 (11.3 %)
Diabetes 14 (8.6 %) 6 (11.3 %) 0.560
Hypertension 26 (16.0 %) 15 (28.3 %) 0.049*
THI 39.22 ± 17.77 45.07 ± 16.63 0.036*
VAS 4.55 ± 1.79 5.37 ± 1.88 0.005*
Haemoglobin 14.08 ± 1.86 14.56 ± 1.39 0.086
Total-C (mg/dl) 193.99 ± 41.52 212.83 ± 46.14 0.006*
VLDL (mg/dl) 31.91 ± 18.67 39.21 ± 25.60 0.059
LDL (mg/dl) 113.18 ± 36.71 131.51 ± 38.12 0.002*
HDL (mg/dl) 47.69 ± 11.63 45.60 ± 11.72 0.257
Triglyceride (mg/dl) 155.98 ± 85.66 196.28 ± 130.12 0.039*
B12 371.80 ± 219.84 386.54 ± 262.29 0.687
Folic acid 7.52 ± 3.61 7.32 ± 2.43 0.813

Total-C total cholesterol, VLDL very low density lipoprotein, LDL low density lipoprotein, HDL high density lipoprotein, HDL high density lipoprotein, THI tinnitus handicap inventory, VAS visual analogue scale

* p < 0.05